Zobrazeno 1 - 10 of 65 pro vyhledávání: '"Hepatitis C/drug therapy"'
1
Akademický článek
Experience of a Portuguese Center: Effectiveness of Direct-Acting Antiviral Therapy for Hepatitis C
Autor: Fátima Falcão, Carla Lopes, Erica Viegas, Rita Perez, Isabel Aldir, Helena Farinha, António Carvalho, Ana Mirco, Susana Marques, Tiago Bana e Costa, Ana Cláudia Miranda, Luís Lebre, Paula Peixe, Cristina Chagas, Kamal Mansinho, José Manuel Correia
Publikováno v: Acta Médica Portuguesa, Vol 32, Iss 3, Pp 189-194 (2019)
Introduction: In late 2014, Portugal implemented a national program for the treatment of patients with chronic hepatitis C with directacting antiviral agents. This program has made Portugal one of the first European countries to implement a structure
Externí odkaz: https://doaj.org/article/5039479f3eb4475ba327d65f1999a35d
Zobrazit plný text záznamu
3
A Human and Rhesus Macaque Interferon-Stimulated Gene Screen Shows That Over-Expression of ARHGEF3/XPLN Inhibits Replication of Hepatitis C Virus and Other Flavivirids
Autor: Bamford, Connor G.C., Aranday-Cortes, Elihu, Sanchez-Velazquez, Ricardo, Mullan, Catrina, Kohl, Alain, Patel, Arvind H., Wilson, Sam J., McLauchlan, John
Publikováno v: Bamford, C G G, Aranday-Cortes, E, Sanchez-Velazquez, R, Mullan, C, Kohl, A, Patel, A H, Wilson, S J & McLauchlan, J 2022, ' A Human and Rhesus Macaque Interferon-Stimulated Gene Screen Shows That Over-Expression of ARHGEF3/XPLN Inhibits Replication of Hepatitis C Virus and Other Flavivirids ', Viruses, vol. 14, no. 8, 1655 . https://doi.org/10.3390/v14081655
Viruses; Volume 14; Issue 8; Pages: 1655
Natural hepatitis C virus (HCV) infection is restricted to humans, whereas other primates such as rhesus macaques are non-permissive for infection. To identify human and rhesus macaque genes that differ or share the ability to inhibit HCV replication
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31d78cd0e01392f4f5b5a1151fc18ef6
https://pure.qub.ac.uk/en/publications/1cd4f023-8e58-41c4-a44e-07f95be62476
Zobrazit plný text záznamu
4
The european prevalence of resistance associated substitutions among direct acting antiviral failures
Autor: Stephanie Popping, Valeria Cento, Carole Seguin-Devaux, Charles Boucher, Adolfo de Salazar, Eva Heger, Orna Mor, Murat Sayan, Dominique Salmon-Ceron, Nina Weis, Henrik Krarup, Robert de Knegt, Oana Săndulescu, Vladimir Chulanov, David van de Vijver, Federico García, Francesca Ceccherini-Silberstein
Publikováno v: Viruses, 14(1):16. Multidisciplinary Digital Publishing Institute (MDPI)
Popping, S, Cento, V, Seguin-Devaux, C, Boucher, C A B, de Salazar, A, Heger, E, Mor, O, Sayan, M, Salmon-Ceron, D, Weis, N, Krarup, H B, de Knegt, R J, Săndulescu, O, Chulanov, V, van de Vijver, D A M C, García, F, Ceccherini-Silberstein, F & on behalf of the HepCare as Part of the European Society for Translational Antiviral Research (ESAR) 2022, ' The european prevalence of resistance associated substitutions among direct acting antiviral failures ', Viruses, vol. 14, no. 1, 16 . https://doi.org/10.3390/v14010016
Viruses, Vol 14, Iss 16, p 16 (2022)
Viruses; Volume 14; Issue 1; Pages: 16
Viruses
Background: Approximately 71 million people are still in need of direct-acting antiviral agents (DAAs). To achieve the World Health Organization Hepatitis C elimination goals, insight into the prevalence and influence of resistance associated substit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::937c5581b8b745059f37ce0f1d267bfb
https://pure.eur.nl/en/publications/c652cd6d-7478-4c1f-be18-cf899bcd0444
Zobrazit plný text záznamu
5
Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019
Autor: Fanciulli C, Berenguer J, Busca C, Vivancos M, Tellez M, Dominguez L, Domingo P, Navarro J, Santos J, Iribarren J, Morano L, Artero A, Moreno J, Rivero-Roman A, Santos I, Giner L, Arminanzas C, Montero M, Manzardo C, Cifuentes C, Garcia C, Galindo M, Ferrero O, Sanz J, de la Fuente B, Rodriguez C, Gaspar G, Perez L, Losa J, Force L, Veloso S, Martinez-Alfaro E, Jarrin I, De Miguel M, Garcia J
Publikováno v: HIV MEDICINE
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-FISABIO. Repositorio Institucional de Producción Científica
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Objectives We assessed the prevalence of anti-hepatitis C virus (HCV) antibodies and active HCV infection (HCV-RNA-positive) in people living with HIV (PLWH) in Spain in 2019 and compared the results with those of four similar studies performed durin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6b942222a99ad99001b3abe1a468d449
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=16392
Zobrazit plný text záznamu
6
Experiência de um Centro Português: Eficácia dos Antivirais de Acção Directa no Tratamento da Hepatite C
Autor: José Manuel Correia, Susana Marques, Isabel Aldir, Paula Peixe, Ana Cláudia Miranda, Luís Lebre, Cristina Chagas, Rita Perez, António Paulo Carvalho, Ana Mirco, Tiago Bana e Costa, E Viegas, Helena Farinha, Carla Lopes, F Falcão, Kamal Mansinho
Publikováno v: Acta Médica Portuguesa, Vol 32, Iss 3, Pp 189-194 (2019)
Acta Médica Portuguesa; v. 32, n. 3 (2019): Março; 189-194
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
In late 2014, Portugal implemented a national program for the treatment of patients with chronic hepatitis C with directacting antiviral agents. This program has made Portugal one of the first European countries to implement a structured measure of t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d747a731b592053251abea5a02df816c
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10655
Zobrazit plný text záznamu
7
MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective
Autor: Fouad, Yasser, Lazarus, Jeffrey V, Negro, Francesco, Peck-Radosavljevic, Markus, Sarin, Shiv K, Ferenci, Peter, Esmat, Gamal, Ghazinian, Hasmik, Nakajima, Atsushi, Silva, Marcelo, Lee, Samuel, Colombo, Massimo
Publikováno v: Alimentary Pharmacology and Therapeutics, Vol. 53, No 10 (2021) pp. 1080-1089
The World Health Organization (WHO) set a goal to eliminate hepatitis C (HCV) infection globally by 2030, with specific targets to reduce new viral hepatitis infections by 80% and reduce related deaths by 65%. However, an overlooked aspect that may h
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1400::f17c623989ebafe741bb79b6c7bd2e7a
https://archive-ouverte.unige.ch/unige:152677
Zobrazit plný text záznamu
8
High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus
Autor: Nicolas Müller, M. Huber, Barbara Hasse, Matthias Hoffmann, Christoph Rudin, Thierry Calandra, Gladys Martinetti, Thomas Klimkait, A. Anagnostopoulos, Helen Kovari, Catia Marzolini, Enos Bernasconi, B Martinez de Tejada, Laurent Kaiser, Karin J. Metzner, Tytti Heinonen, Dominique L Braun, M. Cavassini, Giuseppe Pantaleo, P. Vernazza, Philip E. Tarr, Jürg Böni, Irene T. Schrijver, Marcel Stöckle, Jacques Fellay, Manuel Battegay, Khalid Ohmiti, K. Aebi-Popp, D Haerry, Rainer Weber, Alexandra U. Scherrer, G. Dollenmaier, Hansjakob Furrer, Thierry Roger, Jacobus Herderschee, Christian R Kahlert, Angela Ciuffi, Günthard Hf, Craig Fenwick, Hans H. Hirsch, A. Calmy, Andri Rauch, Irene Hösli, M. Perreau, A. Trkola, Patrick Schmid, Christoph A Fux, G. Pantaleo, Matthias Cavassini, Paolo Paioni, Sabine Yerly, Roger D. Kouyos, Jan Fehr, Olivia Keiser, Dunja Nicca, M Egger, L Elzi, Darius Moradpour, Gilles Wandeler, B Ledergerber, Roberto F. Speck, Heiner C. Bucher
Publikováno v: Clinical microbiology and infection, vol. 28, no. 4, pp. 611.e1-611.e7
Objectives Chronic hepatitis C virus (HCV) infection affects the immune system. Whether elimination of HCV with direct-acting antivirals (DAA) restores immunity is unclear. We used mass cytometry to get a broad and in-depth assessment of blood cell p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0c30428717530d82d30ac275019f4d5
https://doi.org/10.1016/j.cmi.2021.08.018
Zobrazit plný text záznamu
9
A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA
Autor: Hans Wolff, Roberto Monarca, Lara Tavoschi, Éamonn O'Moore, Giordano Madeddu, Anouk M. Oordt-Speets, Sergio Babudieri, Marije Vonk Noordegraaf-Schouten, Marialinda Montanari, Hilde Vroling, Dagmar Hedrich
Publikováno v: Journal of Viral Hepatitis, Vol. 25, No 12 (2018) pp. 1406-1422
Hepatitis C prevalence in prison populations is much higher than in the community. Effective hepatitis C treatment within this population does not only have a direct individual health benefit, but may lead to substantial community dividend. We review
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::133e0b26b98b424f73ab9bb3109b415e
https://doi.org/10.1111/jvh.12998
Zobrazit plný text záznamu
10
Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant
Autor: Berenguer, Juan, Jarrin-Vera, Inmaculada, Pérez-Latorre, Leire, Hontañón, Víctor, Vivancos, María J, Navarro, Jordi, Téllez, María J, Guardiola, Josep M, Iribarren, José A, Rivero-Juárez, Antonio, Márquez, Manuel, Artero, Arturo, Morano, Luis, Santos, Ignacio, Moreno, Javier, Fariñas, María C, Galindo, María J, Hernando, María A, Montero, Marta, Cifuentes, Carmen, Domingo, Pere, Sanz, José, Domíngez, Lourdes, Ferrero, Oscar L, De la Fuente, Belén, Rodríguez, Carmen, Reus, Sergio, Hernández-Quero, José, Gaspar, Gabriel, Pérez-Martínez, Laura, García, Coral, Force, Lluis, Veloso, Sergio, Losa, Juan E, Vilaró, Josep, Bernal, Enrique, Arponen, Sari, Ortí, Amat J, Chocarro, Ángel, Teira, Ramón, Alonso, Gerardo, Silvariño, Rafael, Vegas, Ana, Geijo, Paloma, Bisbe, Josep, Esteban, Herminia, González-García, Juan, GeSIDA 8514 Study Group
Publikováno v: Open Forum Infectious Diseases
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Repisalud
Instituto de Salud Carlos III (ISCIII)
Open forum infectious diseases
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
r-FISABIO. Repositorio Institucional de Producción Científica
Zaguán. Repositorio Digital de la Universidad de Zaragoza
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Background We assessed the prevalence of antibodies against hepatitis C virus (HCV-Abs) and active HCV infection in patients infected with human immunodeficiency virus (HIV) in Spain in 2016 and compared the results with those of similar studies perf
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af12ea5d5b7a7dc4ddc1a6611f783911
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4070
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje